Current filters:  
Bereskin & Parr LLP
Biotechnology companies have a long road to commercialization. Investors, shareholders and company officials often have their patience tested
European Union
DLA Piper
On 7 January 2020, the EU Medical Device Coordination Group published new guidance to help manufacturers fulfil all relevant cybersecurity requirements in Annex I to the new Medical Device Regulations
S.S. Rana & Co. Advocates
The National Medical Commission Act, 2019 (hereinafter referred to as ‘Act') came into force on August 08, 2019.
Nishith Desai Associates
While there has been some significant development in the healthcare sector (specifically in the area of regulating doctors), medical devices sector has clearly witnessed the largest number of developments this year.
STA Law Firm
Kuwait enacted the first mental health law of the country prior to which there was no mental health law in the country.
Saudi Arabia
STA Law Firm
The Saudi 2030 Vision promotes cutting-edge technology in health services for benefit of all the citizen in Kingdom of Saudi Arabia (KSA).
Herbert Smith Freehills
"Health and well-being" is on the Government's radar. Two recent publications, a housing design audit by University College London (UCL) and a Department for Transport survey, prompt...
United Arab Emirates
STA Law Firm
Drugs have destroyed many lives; however, flawed governmental laws have killed many more.
United States
Dickinson Wright PLLC
In 2008, Congress enacted the Paul Wellstone and Pete Domenici Mental Health Parity and Addition Equity Act ("Parity Act").
Dickinson Wright PLLC
The 2020 appropriations act, which was signed into law by the President on December 20, 2019, contains a mix of good and bad news for employer-sponsored health plans.
Over the past month or so, our Health Care Team has published a number of posts examining important developments and trends in health law and policy during 2019
DLA Piper
This regular publication by DLA Piper lawyers focuses on helping clients navigate the ever-changing business, legal and regulatory landscape.
Arnold & Porter
On December 20, 2019, the Further Consolidated Appropriations Act, 2020 (Act) became law. While the Act was primarily designed to provide appropriations...
Buchanan Ingersoll & Rooney PC
Stephanie Schreiber and Bob Ramsey, shareholders in the firm's Healthcare section, presented "Alphabet Soup & Value-Based Payments: Understanding the Legal Pitfalls of CIN" at the HFMA...
Buchanan Ingersoll & Rooney PC
Barbara Binzak Blumenfeld presented at the Phacilitate Leaders/World Stem Cell Summit conference on January 22 in Miami. Her presentation, "Regenerative Medicine Enforcement...
Drug prices continue to be a hot button issue in American politics.
Fenwick & West LLP
The one-week confab centered on the Westin St. Francis Hotel in Union Square is thought to set the stage for life sciences investing for the coming 12 months.
Lewis Brisbois Bisgaard & Smith LLP
Raleigh, N.C. (January 23, 2020) - The numbers are in – the Department of Justice (DOJ) recently published its annual breakdown of false claims litigation undertaken by its Civil Division.
Foley Hoag LLP
Late last year, we noted that the Massachusetts Medicaid program had proposed regulations to address issues related to the prohibition on duplicate discounts in the 340B program.
FDA issued an update to the E. coli O157:H7 illnesses linked to romaine lettuce.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Speaking Engagement Toronto Canada
Font Size:
Mondaq Social Media

  © Mondaq® Ltd 1994 - 2020. All Rights Reserved.